Renalytix Statistics

Total Valuation

Renalytix has a market cap or net worth of GBP 29.50 million. The enterprise value is 32.86 million.

Market Cap	29.50M
Enterprise Value	32.86M

Important Dates

The next estimated earnings date is Wednesday, December 17, 2025.

Earnings Date	Dec 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Renalytix has 437.02 million shares outstanding. The number of shares has increased by 182.86% in one year.

Current Share Class	437.02M
Shares Outstanding	437.02M
Shares Change (YoY)	+182.86%
Shares Change (QoQ)	+62.92%
Owned by Insiders (%)	6.05%
Owned by Institutions (%)	67.24%
Float	351.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.47
PB Ratio	-5.77
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.21
EV / Sales	15.00
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.21

Current Ratio	1.21
Quick Ratio	0.90
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-34.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-160.98%
Return on Invested Capital (ROIC)	-2,656.25%
Return on Capital Employed (ROCE)	-1,307.69%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.45
Inventory Turnover	7.20

Taxes

Income Tax	-1.02M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.57% in the last 52 weeks. The beta is 1.84, so Renalytix's price volatility has been higher than the market average.

Beta (5Y)	1.84
52-Week Price Change	-3.57%
50-Day Moving Average	7.85
200-Day Moving Average	7.80
Relative Strength Index (RSI)	34.76
Average Volume (20 Days)	421,815

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Renalytix had revenue of GBP 2.19 million and -14.89 million in losses. Loss per share was -0.05.

Revenue	2.19M
Gross Profit	875,880
Operating Income	-12.41M
Pretax Income	-15.91M
Net Income	-14.89M
EBITDA	-12.26M
EBIT	-12.41M
Loss Per Share	-0.05

Full Income Statement

Balance Sheet

The company has 2.70 million in cash and 6.06 million in debt, giving a net cash position of -3.36 million or -0.01 per share.

Cash & Cash Equivalents	2.70M
Total Debt	6.06M
Net Cash	-3.36M
Net Cash Per Share	-0.01
Equity (Book Value)	-5.11M
Book Value Per Share	-0.02
Working Capital	729,900

Full Balance Sheet

Cash Flow

Operating Cash Flow	-13.07M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	40.00%
Operating Margin	-566.67%
Pretax Margin	-726.67%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Renalytix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-182.86%
Shareholder Yield	-182.86%
Earnings Yield	-50.48%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Renalytix has an Altman Z-Score of -44.88 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-44.88
Piotroski F-Score	4